Understanding ESR1 Mutations in Resistance to Anti-Estrogens

Exploring the impact of ESR1 mutations in ER-positive metastatic breast cancer, this chapter emphasizes the need for sequencing post-resistance development to detect these mutations for tailored treatment. Discussions delve into the complexities of assessing endocrine sensitivity, highlighting the inferior response of patients with ESR1 mutations to aromatase inhibitors.